Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2003
09/04/2003US20030165517 Administering immunotherapy; induction immunology response
09/04/2003US20030165516 Cytotoxic lumphocyte response; genetic engineering mutants
09/04/2003US20030165515 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
09/04/2003US20030165514 Modulate immunology response
09/04/2003US20030165513 Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
09/04/2003US20030165510 Antiinflammatory agents; anticancer agents; cholesterol binding protein
09/04/2003US20030165506 Novel alpha-catenin expressed in heart and testis
09/04/2003US20030165505 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
09/04/2003US20030165504 Compositions and methods for the therapy and diagnosis of ovarian cancer
09/04/2003US20030165503 Vaccine for the treatment of atherosclerosis
09/04/2003US20030165497 RRP sequences and knockout mice and uses thereof
09/04/2003US20030165496 Alzheimer's disease
09/04/2003US20030165495 Nucleic acids and polypeptides
09/04/2003US20030165493 Antithrombin protein and DNA sequences from black fly
09/04/2003US20030165480 Using swine organs; controlling gene expression
09/04/2003US20030165479 Generating antibodies; modulation polypeptide; adjusting gene expression
09/04/2003US20030165478 Stabilized synthetic immunogen delivery system
09/04/2003US20030165477 Poxvirus with targeted infection specificity
09/04/2003US20030165467 Angiogenic factor and use thereof in treating cardiovascular disease
09/04/2003US20030165464 In vivo stimulation of angiogenic activity
09/04/2003US20030165462 Deleted adenovirus vectors and methods of making and administering the same
09/04/2003US20030165461 Colony stimulating factor culture product; human gene therapy
09/04/2003US20030165460 Proteins which control cell differentiation; immunology response; antiinflammatory agents; wound healing agents
09/04/2003US20030165459 Binding to tumor necrosis factor
09/04/2003CA2743750A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus
09/04/2003CA2513190A1 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
09/04/2003CA2483556A1 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases
09/04/2003CA2477624A1 Transgenic zebrafish models for thrombosis
09/04/2003CA2477569A1 Selective binding of pathological forms of prion proteins using polyionic polymers
09/04/2003CA2477534A1 Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers
09/04/2003CA2477417A1 Methods and products based on oligomerization of stress proteins
09/04/2003CA2477409A1 Process for the preparation of hypoallergenic major birch pollen allergen rbet v 1
09/04/2003CA2477408A1 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
09/04/2003CA2477271A1 Nanostructures containing pilin protein
09/04/2003CA2477270A1 Nanostructures containing antibody assembly units
09/04/2003CA2477249A1 Novel type-1 cytokine receptor glm-r
09/04/2003CA2477235A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
09/04/2003CA2477234A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
09/04/2003CA2477225A1 Novel compositions and methods for cancer
09/04/2003CA2477171A1 Nanostructures containing pna joining or functional elements
09/04/2003CA2477170A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
09/04/2003CA2477094A1 Ricin vaccine and methods of making and using thereof
09/04/2003CA2477037A1 Recombinant negative strand virus rna expression systems and vaccines
09/04/2003CA2477035A1 Protein biomarkers that distinguish prostate cancer from non-malignant cells
09/04/2003CA2477002A1 Assays to monitor amyloid precursor protein processing
09/04/2003CA2476942A1 Assay for activity of the actriib kinase
09/04/2003CA2476887A1 Gasp1:a follistatin domain containing protein
09/04/2003CA2476846A1 Method for detection of leptin receptor ligands
09/04/2003CA2476666A1 Haemophilus adherence and penetration proteins
09/04/2003CA2476654A1 Follistatin domain containing proteins
09/04/2003CA2476571A1 Method for isolating ligands
09/04/2003CA2476518A1 Compositions and methods for the treatment of immune related diseases
09/04/2003CA2476480A1 Methods of making hypermutable cells using pmsr homologs
09/04/2003CA2475526A1 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
09/04/2003CA2475433A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications
09/04/2003CA2474751A1 Expression system for human brain-specific voltage-gated sodium channel, type 1
09/04/2003CA2473340A1 Formulations comprising a glp-1 compound and a delivery agent, and uses thereof
09/04/2003CA2471307A1 Protein complexes and methods for their use
09/04/2003CA2459155A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
09/03/2003EP1340981A2 Antibodies for detecting amphetamine derivatives
09/03/2003EP1340980A1 Derivatives of amphetamine, antibodies against said derivatives, reagent kits, methods of producing said antibodies, and methods of detecting said derivatives
09/03/2003EP1340979A2 Neuropeptide receptor and uses thereof
09/03/2003EP1340821A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340820A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340817A1 Assay for activity of the actRIIB kinase
09/03/2003EP1340815A2 Determination of alpha-N-acetylgalactosaminidase activity
09/03/2003EP1340812A2 Functional domains in flavobacterium okeanokoites (Foki) restriction endonuclease
09/03/2003EP1340769A1 CD4-gamma2 and CD4-IgG2 chimeras
09/03/2003EP1340767A2 Polypeptide useful as biomaterial and process for producing the same
09/03/2003EP1340084A2 Proteins, genes and their use for diagnosis and treatment of chronic asthma
09/03/2003EP1340079A2 S. aureus protein staau-r2, gene encoding it and uses thereof
09/03/2003EP1339867A2 ALTERATIONS IN THE LONG QT SYNDROME GENES i KVLQT1 /i AND i SCN5A /i AND METHODS FOR DETECTING SAME
09/03/2003EP1339860A2 Novel targets for herbicides and transgenic plants resistant to said herbicides
09/03/2003EP1339857A2 Enhancement of freezing tolerance in transgenic plants
09/03/2003EP1339856A1 Production of heterologous polypeptides in yeast
09/03/2003EP1339855A2 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
09/03/2003EP1339851A2 Basb221 polypeptides and polynucleotides encoding basb221 polypeptides
09/03/2003EP1339850A2 A novel cocoa albumin and its use in the production of cocoa and chocolate flavour
09/03/2003EP1339849A2 PLANT POLYNUCLEOTIDES ENCODING NOVEL Na+ /H+ ANTIPORTERS
09/03/2003EP1339848A2 A novel protein selectively expressed in osteoblasts
09/03/2003EP1339847A2 Transforming growth factor-beta-related molecules and uses thereof
09/03/2003EP1339846A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339845A2 Adipocyte complemented related protein zacrp3x2
09/03/2003EP1339844A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339843A2 Human transporter proteins nucleic acid molecules encoding them and uses thereof
09/03/2003EP1339842A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339841A2 Identification of neuroblastoma tumor suppressor genes
09/03/2003EP1339840A2 Schizophrenia-related voltage-gated ion channel gene and protein
09/03/2003EP1339839A2 Human transporter family members and uses thereof
09/03/2003EP1339828A2 Yeast-based assays involving gpcrs
09/03/2003EP1339798A2 Sulfonated diarylrhodamine dyes
09/03/2003EP1339749A1 Dextran-hemoglobin conjugates as blood substitutes
09/03/2003EP1339748A2 G-protein coupled receptors
09/03/2003EP1339747A2 Membrane fusion proteins derived from reovirus
09/03/2003EP1339746A2 Binding polypeptides for b lymphocyte stimulator protein (blys)
09/03/2003EP1339745A1 Immunotherapeutic methods and molecules
09/03/2003EP1339744A2 Production of recombinant bmp-2
09/03/2003EP1339743A2 Compositions and methods for diagnosing alzheimer's disease
09/03/2003EP1339742A2 Human protein differentially expressed in alzheimer's disease's brain
09/03/2003EP1339741A2 Human sprouty-4 polypeptide
1 ... 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 ... 2916